This collection contains guidelines, forms and documents related to accessing galsulfase (Naglazyme®) under the LSDP. Click to view the Naglazyme® product information on the Therapeutic Goods Administration website.
Medicines review documents
We aim to provide documents in an accessible format. If you're having problems using a document with your accessibility tools, please contact us for help.